SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-097835
Filing Date
2017-03-27
Accepted
2017-03-27 17:21:56
Documents
3
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13D d368260dsc13d.htm SC 13D 90252
2 EX-1 d368260dex1.htm EX-1 5882
3 EX-2 d368260dex2.htm EX-2 43079
  Complete submission text file 0001193125-17-097835.txt   140860
Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Filed by) CIK: 0001297709 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Subject) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83932 | Film No.: 17716179
SIC: 2834 Pharmaceutical Preparations